Kazia Therapeutics Limited
KZIA
$13.16
-$0.67-4.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.12M | -4.11M | -3.28M | -3.21M | -3.41M |
| Total Depreciation and Amortization | -- | -- | -200.00 | -200.00 | 304.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.21M | 1.21M | 2.35M | 2.30M | 708.90K |
| Change in Net Operating Assets | -224.30K | -223.60K | -618.50K | -605.70K | -350.90K |
| Cash from Operations | -3.13M | -3.12M | -1.56M | -1.52M | -2.74M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27.72M | 27.72M | 1.96M | 1.96M | 4.28M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.94M | 9.94M | 1.16M | 1.16M | 589.10K |
| Cash from Financing | 24.72M | 24.64M | 2.00M | 1.96M | 3.17M |
| Foreign Exchange rate Adjustments | -218.40K | -217.70K | -33.10K | -32.40K | 28.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.37M | 21.30M | 410.40K | 401.80K | 458.40K |